IL6 and type 2 diabetes mellitus: According to Currenti et al. [29], the reduction in adipose tissue in people with type 2 diabetes on low-carbohydrate diets decreases the release of pro-inflammatory adipokines, including tumour necrosis factor alpha and interleukin 6, which have been reported to contribute to low-grade systemic inflammation and insulin resistance.